| Cevimeline |
| (+/-)-cis-2-Methylspiro[1,3-oxathiolane-5,3’-quinuclidine] |
| (CAS 107233-08-9) |
 |
| Description： |
Cevimeline (Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M3 receptors; used in the treatment of dry mouth associated with sjogren's syndrome.
IC50 value:
Target: M3 receptor |
| Product No. |
KT20419 |
| Product Name |
Cevimeline |
| Synonyms |
Evoxac |
| Formal Name |
(+/-)-cis-2-Methylspiro[1,3-oxathiolane-5,3’-quinuclidine] |
| CAS Number |
107233-08-9 |
| Molecular Formula |
C10H17NOS |
| Formula Weight |
199.31 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
mAChR
Darifenacin
Diphenmanil methylsulfate
Fesoterodine fumarate
Flavoxate hydrochloride
Gallamine Triethiodide
Glycopyrrolate
Homatropine Bromide
Ipratropium bromide
Irsogladine
L-Hyoscyamine
mAChR-IN-1
|
|
